On the chart you can see the default numbers in dynamics for ResMed Inc. (RMD). Companys revenue shows the average of 1165.686 M which is 0.272 % gowth. The average gross profit for the whole period is 685.376 M which is 0.262 %. The average gross profit ratio is 0.612 %. The net income growth for the company last year performance is 0.152 % which equals 0.363 % % on average for the whole company history.,
Diving into the fiscal trajectory of ResMed Inc., we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to 0. A look back at the past year reveals a total asset change of 0.325. In the realm of current assets, RMD clocks in at 2367.83 in the reporting currency. A significant portion of these assets, precisely 227.891, is held in cash and short-term investments. This segment shows a change of -0.167% when juxtaposed with last year's data. The debt profile of the company shows a total long-term debt of 1548.087 in the reporting currency. This figure signifies a year_over_year change of 0.722%. Shareholder value, as depicted by the total shareholder equity, is valued at 4129.903 in the reporting currency. The year over year change in this aspect is 0.229%. A deeper dive into the company's financials reveals additional details. The net receivables are valued at 704.909, with an inventory valuation of 998.01, and goodwill valued at 2770.3, if any. The total intangible assets, if present, are valued at 552.34. Account payables and short-term debt are 150.76 and 31.82, respectively. The total debt is 1579.91, with a net debt of 1352.02. Other current liabilities amount to 437.88, adding to the total liabilities of 2621.8. Lastly, the referred stock is valued at 0, if it exists.
The financial landscape of ResMed Inc. has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of 1.867. The company recently extended its share capital by issuing 49.14, marking a difference of 0.341 compared to the previous year. Interestingly, a portion of the company's stock, specifically 1070, was bought back by the company itself. This action resulted in a change of -21.418 from the previous year. Meanwhile, the company's account payables are currently standing at 31.34 in the reporting currency. The company's investing activities resulted in net cash usage, amounting to -1159845000.000 in the reporting currency. This is a shift of 4.045 from the previous year. In the same period, the company recorded 197.56, 0, and -405, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of 0.000, with a year over year difference of 0.000. Furthermore, the company allocated -258.28 for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as -32.99, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.
ResMed Inc.'s revenue saw a change of 0.180% compared with the previous period. The gross profit of RMD is reported to be 2355.66. The company's operating expenses are 1203.66, showing a change of 17.543% from the last year. The expenses for depreciation and amortization are 197.56, which is a 0.019% change from the last accounting period. Operating expenses are reported to be 1203.66, which shows a 17.543% year-over-year change. Selling and marketing expenses are 0, which is a 0.000% change compared to the previous year. The EBITDA based on the recent numbers is 0, representing a 0.132% year-over-year growth. The operating income is 1131.87, which shows a 0.132% change when compared to the previous year. The change in the net income is 0.152%. The net income for the last year was 897.56.
